Related Experiment Video
Updated: Jun 7, 2025

Rapid and Specific Detection of Acinetobacter baumannii Infections Using a Recombinase Polymerase Amplification/Cas12a-based System
Published on: April 25, 2025
ERA-CRISPR/Cas12a-based, fast and specific diagnostic detection for Chlamydia pneumoniae
Yanxia Zhou1, Zijun Yan1, Shi Zhou1
1The Institute of Pathogenic Biology, Hengyang Medical School, University of South China, Hengyang, China.
Abstract:
Chlamydia pneumoniae (C. pneumoniae) is a specialized intracellular parasitic pathogen capable of causing pneumonia, sinusitis, bronchitis, and other respiratory diseases, which pose significant public health challenges. Therefore, rapid, accurate, and sensitive diagnosis is crucial for the prevention and treatment of respiratory diseases caused by C. pneumoniae. In this study, we combined enzymatic recombination amplification (ERA) with the clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein (Cas) 12a system (CRISPR/Cas12a) to develop a dual detection platform termed the Cpn-ERA-CRISPR/Cas12a dual system. This system integrates both the ERA-CRISPR/Cas12a fluorescence system and the ERA-CRISPR/Cas12a lateral flow system. Detection results can be measured using a fluorescence detector or observed with the naked eye on lateral flow strips. The fluorescence system and the lateral flow system detect C. pneumoniae in 30 minutes and 15 minutes, respectively. This dual system exhibits no cross-reactivity with the other seven pathogens, demonstrating high specificity, and achieves a sensitivity of 100 copies/µL. Additionally, the Cpn-ERA-CRISPR/Cas12a dual system was employed to analyze 39 clinical samples, comprising 19 positive and 20 negative samples. The detection rate for positive samples was 100%, with no positive results in the negative samples, indicating a high level of concordance with qPCR results. In summary, the Cpn-ERA-CRISPR/Cas12a dual system represents a novel tool for diagnosing C. pneumoniae and holds promising application potential in grassroots community hospitals.
Insights
A new dual detection system combining enzymatic recombination amplification (ERA) and CRISPR/Cas12a rapidly and accurately diagnoses Chlamydia pneumoniae (C. pneumoniae) infections. This sensitive tool shows promise for community healthcare settings.
Area of Science:
- Microbiology
- Molecular Diagnostics
- Infectious Diseases
Background:
- Chlamydia pneumoniae (C. pneumoniae) causes significant respiratory illnesses like pneumonia.
- Accurate and rapid diagnosis of C. pneumoniae is critical for effective treatment and public health.
- Existing diagnostic methods may lack the speed or sensitivity required for widespread application.
Purpose of the Study:
- To develop a novel, rapid, and sensitive dual detection platform for C. pneumoniae.
- To integrate enzymatic recombination amplification (ERA) with CRISPR/Cas12a technology.
- To evaluate the diagnostic performance of the Cpn-ERA-CRISPR/Cas12a dual system.
Main Methods:
- Development of a dual system combining ERA with CRISPR/Cas12a fluorescence and lateral flow assays.
- Testing the system's specificity against seven other common pathogens.
- Assessing the system's sensitivity using known C. pneumoniae concentrations (10^0 copies/µL).
- Validation using 39 clinical samples compared against quantitative PCR (qPCR).
Main Results:
- The Cpn-ERA-CRISPR/Cas12a dual system achieved detection in 30 minutes (fluorescence) and 15 minutes (lateral flow).
- Demonstrated high specificity with no cross-reactivity and a sensitivity of 10^0 copies/µL.
- Achieved 100% detection rate in positive clinical samples and 0% in negative samples, matching qPCR results.
Conclusions:
- The Cpn-ERA-CRISPR/Cas12a dual system offers a novel, rapid, and highly accurate diagnostic tool for C. pneumoniae.
- The system's dual fluorescence and lateral flow formats provide flexibility for different clinical settings.
- This technology holds significant potential for improving C. pneumoniae diagnostics in community healthcare.
Related Concept Videos
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
Pneumonia III: Complications and Assessment
Bacterial Phylum Chlamydiae

